Who are Bioseal Fibrin Sealant's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Fibrin Sealant Grifols, Fibrin Sealant 2 (FS2).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bioseal-fibrin-sealant.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Bioseal Fibrin Sealant — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bioseal Fibrin Sealant (Bioseal Fibrin Sealant) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Fibrin sealant / Hemostatic agent. Area: Surgery / Hemostasis.

marketed Fibrin sealant / Hemostatic agent Surgery / Hemostasis Biologic Live · refreshed every 30 min

Target snapshot

Bioseal Fibrin Sealant (Bioseal Fibrin Sealant) — Ethicon, Inc.. Bioseal Fibrin Sealant is a topical hemostatic agent that forms a fibrin clot to seal tissue surfaces and control bleeding during surgery.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Bioseal Fibrin Sealant TARGET	Bioseal Fibrin Sealant	Ethicon, Inc.	marketed	Fibrin sealant / Hemostatic agent
Fibrin Sealant Grifols	Fibrin Sealant Grifols	Instituto Grifols, S.A.	phase 3	Fibrin sealant / Hemostatic agent	Fibrinogen (substrate for thrombin-catalyzed polymerization)
Fibrin Sealant 2 (FS2)	Fibrin Sealant 2 (FS2)	Ethicon, Inc.	phase 3	Fibrin sealant / Hemostatic agent	Fibrinogen and thrombin (coagulation cascade)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Fibrin sealant / Hemostatic agent class)

Ethicon, Inc. · 2 drugs in this class
Instituto Grifols, S.A. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bioseal Fibrin Sealant — Competitive Intelligence Brief. https://druglandscape.com/ci/bioseal-fibrin-sealant. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab